2022-11-25 09:54:00

Flu tests from R-Biopharm also detect new virus variants

Logo RealWire

Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.

"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. "Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."

This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.

About R-Biopharm
R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis.

R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.

Press contact:
Simone Feiler
Head of Corporate Brand Communication


R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt
Phone: 0 61 51 - 81 02-538
Mobile: 0 160 - 55 273 60
Fax: 0 61 51 - 81 02-40
Email: s.feiler@r-biopharm.de

Source: RealWire

Continue read on realwire.com

Logo PR Newswire
HealthPress Release2022-11-24 16:45:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC),...

Logo Daily Mail
HealthBy Caitlin Tilley2022-11-24 22:48:41
Scientists have created a super-vaccine that can fight every known strain of flu and uses the same technology used in Covid shots. The experimental vaccine -...

Logo BBC
HealthBy Https://Www Facebook Com/Bbcnews2022-11-25 02:00:05
By Michelle Roberts Digital health editor Scientists say they have made a breakthrough designing a vaccine against all 20 known types of flu. It uses the...

Logo The Independent
HealthBy Rebecca Thomas2022-11-24 11:54:02
Hundreds of hospital beds are being filled by flu patients, a ten-fold increase on last year, prompting fears the NHS faces a triple-demic this winter. NHS...

Business / FinanceBy Spencer Kimball2022-11-18 21:24:07
Key Points The H3N2 variant has been associated with more severe flu seasons for children and the elderly in the past, according to the CDC. Public health...

Logo The Independent
HealthBy Holly Bancroft2022-11-25 08:56:54
Scientists say they have made a breakthrough in designing a universal vaccine that could protect against flu. It will protect against all 20 known types of...

Logo The Guardian
PoliticsBy Andrew Gregory2022-11-24 16:09:50
The NHS is facing a perfect winter storm with 10 times more people in hospital with flu than this time last year, and ambulances experiencing deadly delays...

Logo Benzinga
Business / FinanceBy Pr Newswire2022-11-23 15:30:00
The seasonal influenza market size is anticipated to increase in the coming years owing to the launch of the emerging therapies and vaccines. The current...

Logo PR Newswire
HealthPress Release2022-11-23 15:30:00
The seasonal influenza market size is anticipated to increase in the coming years owing to the launch of the emerging therapies and vaccines. The current...

Logo Daily Mail
HealthBy John Ely Senior2022-11-24 10:53:03
A winter of reckoning has come for the NHS with flu admissions already 10 times higher than last year, with hospital beds and ambulance delays also sky high...

Logo PR Newswire
HealthPress Release2022-11-24 10:45:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Technological Innovations and Growth Opportunities in Diagnostic Biochips" report has been added to...

Logo Daily Mail
HealthBy Luke Andrews2022-11-23 20:11:08
Experts today slammed the US Government for failing to stock up on key flu drugs and antibiotics during the pandemic despite warnings that a whirlwind of...

Logo BBC
HealthBy Https://Www Facebook Com/Bbcnews2022-11-23 17:32:05
By Madeline Halpert BBC News, Washington With the holiday season approaching in the US, doctors are urging people to exercise caution to avoid a surge in...

Logo Global News
HealthBy Teresa Wright2022-11-23 21:32:43
With flu activity in Canada reaching well above typical levels, infectious diseases experts are concerned about lower uptake of the flu shot, especially...

Logo PR Newswire
HealthPress Release2022-11-25 07:41:00
GOTHENBURG, Sweden, Nov. 25, 2022 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that analysis of the AGENT study's...

Logo PR Newswire
HealthPress Release2022-11-24 10:29:00
JERSEY CITY, N.J., Nov. 24, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled " Global GMP...

Logo Global News
HealthBy The Canadian Press2022-11-25 00:17:10
As doctors worry older adults will be the next wave to become seriously ill by respiratory syncytial virus, Health Canada is reviewing a vaccine to help...

Logo EIN Presswire
SciencePress Release2022-11-24 14:21:41
Long Covid effect continues Anirban Datta Verseon Head of Biology Paul Stannard, Chairman of the World Nano Foundation

Logo Daily Mail
HealthBy Stephen Matthews2022-11-24 17:19:57
It's not just 'football fever' that could spread at this year's World Cup. World Health Organization-backed experts fear 'camel flu' a deadlier cousin of...

Logo EIN Presswire
HealthPress Release2022-11-24 11:23:19
Catheter Related Blood Stream Infection Market Catheter related bloodstream infection arise due to presence of bacteremia at tip of catheter or in between...